NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-025-2022-0-JP-01 CD28 HINGE AND TRANSMEMBRANE CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GPC2 AND USE THEREOF JP National Stage 2024-547534 Pending
NIAID E-047-2022-0-CA-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses CA National Stage 3251161 Pending
NCATS E-218-2021-0-CA-01 FUSED DIAZEPINES AS AGONISTS OF THE INSULIN-LIKE 3 (INSL3) PEPTIDE RECEPTOR RXFP2 AND METHODS OF USE THEREOF CA National Stage 3243968 Pending
NIAID E-047-2022-0-AE-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses AE National Stage P2024-02085 Pending
NIAID E-018-2018-0-US-02 CHIMERIC VECTORS US CON 18/799,179 Pending
NCI E-158-2023-0-PC-01 POLYFLUORINATED THALIDOMIDE ANALOGS AND USES THEREOF PCT PCT PCT/US2024/041504 Expired
NCI E-045-2022-0-EP-01 Method of HLA loss Heterozygosity Detection in Liquid Biopsies EP National Stage 23705845.8 Pending
NCATS E-218-2021-0-US-02 SMALL MOLECULE AGONISTS OF THE INSULIN-LIKE 3 (INSL3) PEPTIDE RECEPTOR RXFP2 AND METHODS OF USE THEREOF US National Stage 18/837,100 Pending
NIAID E-047-2022-0-QA-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses QA National Stage QA/202408/00619 Pending
NIAID E-047-2022-0-ZA-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses ZA National Stage 2024/06123 Pending
NIAID E-047-2022-0-SA-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses SA National Stage 1120244388 Pending
NIAID E-047-2022-0-PH-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses PH National Stage 1-2024-551911 Pending
NIAID E-079-2018-0-US-02 ANTIBODIES AND METHODS FOR THE DIAGNOSIS, PREVENTION, AND TREATMENT OF EPSTEIN BARR VIRUS INFECTION US DIV 18/796,697 Pending
NINDS E-195-2023-0-US-01 SHORT HAIRPIN RNA-MEDIATED INHIBITION OF HERV-K EXPRESSION AND USES THEREOF US 63/680,228 Expired
NICHD E-003-2014-0-US-03 MONOCLONAL ANTIBODIES THAT SPECIFICALLY BIND TO MATRILIN 3 AND THEIR USE US CON 18/796,807 Pending
NIAID E-047-2022-0-NG-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses NG National Stage F/PT/PCT/2024/13748 Pending
NIAID E-047-2022-0-BR-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses BR National Stage BR112024016168-4 Pending
NCI E-025-2022-0-CA-01 CD28 HINGE AND TRANSMEMBRANE CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GPC2 AND USE THEREOF CA National Stage 3251361 Pending
NHLBI E-144-2021-0-CN-01 Guidewire for Electrosurgical Tissue Laceration CN National Stage 202380020439.8 Pending
NCI E-150-2017-2-JP-03 Diagnostic Methods For T Cell Therapy JP DIV 2024-129905 Pending
NIAID E-047-2022-0-KW-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses KW National Stage 2024/003073 Pending
NEI E-015-2019-0-SG-12 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE SG DIV 10202402344U Pending
NIAID E-047-2022-0-OM-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses OM National Stage OM/P/2024/000492 Pending
NIAID E-047-2022-0-IL-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses IL National Stage 314799 Pending
NIAID E-047-2022-0-BH-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses BH National Stage 2024-02-28 Pending
NIAID E-047-2022-0-US-02 Human Monoclonal Antibodies That Broadly Target Coronaviruses US National Stage 18/835,912 Pending
NCI E-176-2014-0-JP-02 ANTI-HUMAN PAPILLOMAVIRUS 16 E7 T CELL RECEPTORS JP DIV 2024-126652 Issued
NIAID E-083-2017-0-US-06 GLYCAN-MASKED ENGINEERED OUTER DOMAINS OF HIV-1 GP120 AND THEIR USE US DIV 18/793,025 Pending
NCATS E-057-2022-0-EP-01 ESTRADIOL PRODRUGS AND METHODS OF USE THEREOF EP National Stage 23737785.8 Pending
NCI E-214-2024-0-US-01 CHIMERIC ANTIGEN RECEPTORS TARGETING THE GAMMA DELTA T CELL RECEPTOR US 63/678,625 Expired
NIAID E-047-2022-0-MY-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses MY National Stage PI2024004517 Pending
NIAID E-531-2013-2-BR-01 Epstein-Barr Virus Vaccines BR DIV BR122024015865-5 Pending
NIAID E-211-2024-0-US-01 SARS-CoV-2 VACCINE US 63/678,464 Expired
NICHD E-058-2021-0-US-03 La Protein As A Novel Regulator Of Osteoclastogenesis US DIV 18/791,272 Pending
NCI E-234-2014-1-JP-03 METHOD FOR PRODUCING AUTOLOGOUS T-CELL USEFUL TO TREAT B-CELL MALIGNANCY AND OTHER CANCER, AND COMPOSITION THEREOF JP DIV 2024-124165 Pending
NIAID E-200-2024-0-US-01 WEST NILE VIRUS NEUTRALIZING MONOCLONAL ANTIBODIES US 63/677,612 Expired
NCATS E-204-2022-5-PC-01 MULTI-CYCLIC IRAK1 AND IRAK4 INHIBITING COMPOUNDS AND USES THEREOF PCT PCT PCT/US2024/040403 Expired
NCI E-264-2011-0-EP-01 Delivery Of Packaged RNA To Mammalian Cells EP DIV 24191846.5 Pending
NIBIB E-157-2023-0-PC-01 METHOD AND SYSTEM FOR RAPID SPECTRAL UNMIXING USING SPECTRALLY INTERPOLATED BACKGROUND REDUCTION PCT PCT PCT/US2024/039976 Expired
NICHD E-026-2019-0-US-02 POLYPEPTIDES, NUCLEIC ACID MOLECULES, COMPOSITIONS, AND RELATED METHODS US DIV 18/786,697 Pending
NCI E-040-2012-0-KR-01 CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN KR DIV 10-2024-7025571 Pending
NHLBI E-124-2014-3-US-05 Devices and Methods for Delivery of Expandable Prostheses US CON 18/786,552 Pending
NHLBI E-035-2022-0-US-02 PREPARATION OF ISOTOPICALLY LABELED KETOGLUTARATES AND METHODS OF HYPERPOLARIZATION THROUGH SIGNAL AMPLIFICATION BY REVERSIBLE EXCHANGE (SABRE) US National Stage 18/833,627 Pending
NHLBI E-035-2022-0-JP-01 PREPARATION OF ISOTOPICALLY LABELED KETOGLUTARATES AND METHODS OF HYPERPOLARIZATION THROUGH SIGNAL AMPLIFICATION BY REVERSIBLE EXCHANGE (SABRE) JP National Stage 2024-544466 Abandoned
NCI E-042-2014-0-AU-01 Chimeric Antigen Receptors Targeting CD-19 AU DIV 2024205043 Pending
NCI E-183-2017-0-JP-02 ANTI-B-CELL MATURATION ANTIGEN CHIMERIC ANTIGEN RECEPTORS WITH HUMAN DOMAINS JP DIV 2024-118255 Issued
NIA E-024-2022-0-US-02 GINGERENONE A PRODRUGS AS SENOTHERAPEUTICS AND METHODS OF USE US National Stage 18/832,248 12325688 Issued PDF
NIA E-024-2022-0-US-03 GINGERENONE A PRODRUGS AND METHODS OF USE US CIP 18/780,981 Pending
NHLBI E-035-2022-0-EP-01 PREPARATION OF ISOTOPICALLY LABELED KETOGLUTARATES AND METHODS OF HYPERPOLARIZATION THROUGH SIGNAL AMPLIFICATION BY REVERSIBLE EXCHANGE (SABRE) EP National Stage 23707534.6 Pending
NCI E-025-2022-0-AU-01 CD28 HINGE AND TRANSMEMBRANE CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GPC2 AND USE THEREOF AU National Stage 2023221836 Pending